Related Experiment Video
Updated: Aug 11, 2026

A Magnetic Resonance Imaging Protocol for Stroke Onset Time Estimation in Permanent Cerebral Ischemia
Published on: September 16, 2017
C-reactive protein is an indicator for fatal outcomes in first-time stroke patients
Abdulkadir Koçer1, Cüneyt Canbulat, Eren Gözke
1Department of Neurology, PTT Teaching Hospital, Istanbul, Turkey. abdulkadirkocer@yahoo.com
Insights
Elevated high-sensitivity C-reactive protein (hsCRP) levels are significantly higher in first-time ischemic stroke patients compared to controls. High hsCRP may indicate a fatal outcome within six months for these patients.
Area of Science:
- Cardiology
- Neurology
- Inflammation Research
Background:
- The link between high-sensitivity C-reactive protein (hsCRP) and ischemic cerebrovascular disease is not fully understood.
- Inflammatory processes are suspected to play a role in stroke development.
Purpose of the Study:
- To compare serum hsCRP levels in ischemic stroke patients versus a control group.
- To investigate correlations between hsCRP levels and known risk factors for stroke.
Main Methods:
- 47 ischemic stroke patients and 26 controls were enrolled, matched for age and sex.
- Serum hsCRP levels were measured using a chemiluminescence assay 12-24 hours post-stroke.
Main Results:
- Stroke patients exhibited significantly higher mean hsCRP levels (3.12 ± 4.4 mg/dL) than controls (0.39 ± 0.6 mg/dL).
- Elevated hsCRP levels were observed in 83% of patients and 27% of controls.
- hsCRP correlated with hypertension and predicted death within six months, but not other vascular risk factors besides cholesterol.
Conclusions:
- Elevated serum hsCRP levels may serve as a prognostic marker for adverse outcomes in first-time ischemic stroke patients.
- This finding highlights the potential role of inflammation in stroke severity and prognosis.
Background:
The causal relation of high sensitivity C-reactive protein (hsCRP) to ischemic cerebrovascular disease remains unclear, though an inflammatory effect has been suggested in many studies. The aim of our study was to evaluate serum hsCRP levels in ischemic stroke patients and in a control group, and to correlate the values with other generally known risk factors.
Material/Methods:
A total of 47 patients with ischemic stroke and 26 control subjects were recruited. The cases were well-matched to controls for age and sex. Peripheral blood samples from stroke patients were obtained between 12-24 hours after the stroke. Serum levels of hsCRP were determined by chemoluminescence assay.
Results:
The mean serum levels of hsCRP were found to be significantly higher in patients (3.12 +/- 4.4 mg/dL) than controls (0.39 +/- 0.6 mg/dL, p=0.0001). The level of hsCRP was above the risk limit in 39 patients (83.0%) and 7 controls (26.9%). The hsCRP values were not related to the presence of other vascular risk factors, except for cholesterol level. The correlation analysis of hsCRP revealed a linear correlation with death within six months and the presence of hypertension.
Conclusions:
Our results suggest that elevated serum hsCRP levels may be an indicator of fatal outcome in first-time stroke patients.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Ischemic Stroke ll: Pathophysiology

